An anonymous director reports

PSYENCE LOOKS TO EXPAND CAPITAL MARKET OPPORTUNITIES IN THE UK AND EUROPE

Psyence Group Inc. is exploring capital market opportunities to access a broader pool of United Kingdom and European investors. This includes a potential dual listing in the United Kingdom.

This forms part of the company's strategy to constantly monitor and review its position within global capital markets with the view of maximizing returns for investors and increasing liquidity, as well as supporting the company's growth and value generation.

Psyence is a global company with operations in Canada, the United Kingdom, Jamaica, South Africa and Lesotho, and a presence in the United States and Australia. The company has a worldwide investor base, including shareholders in the United Kingdom and Europe, and is initiating a clinical trial in the United Kingdom using its natural psilocybin in the field of palliative care with oncology patients.

About Psyence Group Inc.

Psyence is a life science biotechnology company listed on the Canadian Securities Exchange and quoted on the OTCQB, with a focus on natural psychedelics. Psyence works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care.

The name Psyence combines the words psychedelic and science to affirm the company's commitment to producing psychedelic medicines developed through evidence-based research.

Informed by nature and guided by science, the company built and operates one of the world's first federally licensed commercial psilocybin mushroom cultivation and production facilities in Lesotho, southern Africa. The company's team brings international experience in both business and science, and includes experts in mycology, neurology, palliative care and drug development. The company works to develop advanced natural psilocybin products for clinical research and development.

The company's key divisions, Psyence Production, Psyence Therapeutics and Psyence Function, anchor an international collaboration, with operations in Canada, the United Kingdom, Jamaica, South Africa and Lesotho, and a presence in the United States and Australia.

We seek Safe Harbor.